Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | QPCT | Q16769 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 9/20 | 0.39 |
| ▸ | CA2 | P00918 | 9/20 | 0.39 |
| ▸ | CA9 | Q16790 | 8/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA7 | P43166 | 3/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.38 |
| ▸ | CA3 | P07451 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA6 | P23280 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Methylimidazole SCHEMBL5491564 | 0.99 | TBXAS1 (0.44) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| 1-Methylimidazole SCHEMBL38665424 | 0.99 | TBXAS1 (0.44) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL22371488 | 0.85 | TBXAS1 (0.65) | TBXAS1TBXA2RHTTSMN1; SMN2MAPK1 | |
| 1-Methylimidazole SCHEMBL993256 | 0.83 | NFKB1 (0.52) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| 1-Methylimidazole SCHEMBL15778945 | 0.82 | QPCT (0.47) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| 1-Methylimidazole SCHEMBL6672630 | 0.82 | HSD17B10 (0.47) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| 1-Methylimidazole SCHEMBL16280485 | 0.81 | TBXAS1 (0.41) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL13276105 | 0.80 | TBXAS1 (0.37) | TBXAS1CA1CA2CA9CA12 | |
| Hexane SCHEMBL28254403 | 0.79 | QPCT (0.71) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| Hexane SCHEMBL27685940 | 0.79 | QPCT (0.71) | NFKB1QPCTHSD17B10QPCTLTBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070219379-A1 | Ionic Liquid and Process for Producing the Same | KANEKA CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219379-A1 | Ionic Liquid and Process for Producing the Same | HCN4, HCN2, HCN3 | NFKB1 3270/4885QPCT 1502/4885HSD17B10 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.